Cart
sales@molnova.com
MAPK13-IN-1
CAS No. 229002-10-2
MAPK13-IN-1( —— )
Catalog No. M33008 CAS No. 229002-10-2
MAPK13-IN-1 is a potent MAPK13 (p38δ) inhibitor (IC50: 620 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 152 | Get Quote |
|
| 5MG | 235 | Get Quote |
|
| 10MG | 353 | Get Quote |
|
| 25MG | 592 | Get Quote |
|
| 50MG | 857 | Get Quote |
|
| 100MG | 1224 | Get Quote |
|
| 500MG | 2448 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMAPK13-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionMAPK13-IN-1 is a potent MAPK13 (p38δ) inhibitor (IC50: 620 nM).
-
DescriptionMPAK13-IN-1 is a MAPK13 (p38δ) inhibitor, with an IC50 of 620 nM.
-
In VitroCell Viability Assay Cell Line:Vero E6 cells.Concentration:0-100 μM.Incubation Time:Result:Exhibited an IC50 of 4.63 μM.
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
Targetp38 MAPK
-
Recptorp38 MAPK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number229002-10-2
-
Formula Weight365.43
-
Molecular FormulaC20H23N5O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 250 mg/mL (684.13 mM)
-
SMILESCn1nc(cc1NC(=O)Nc1ccc(Oc2ccncc2)cc1)C(C)(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yurtsever Z, et al. First comprehensive structural and biophysical analysis of MAPK13 inhibitors targeting DFG-in and DFG-out binding modes. Biochim Biophys Acta. 2016 Nov;1860(11 Pt A):2335-2344.?
molnova catalog
related products
-
MW-150
MW-150 (MW01-18-150 SRM) is a novel potent, selective, CNS penetrant and orally active inhibitor of p38α MAPK with Ki of 101 nM.
-
VX-745
A potent and selective p38α kinase inhibitor with IC50 of 9 nM; shows 20-fold selectivity for p38α over p38β (Ki=220 nM) and no significant inhibition for MAP kinases (with the exception of MKK6).
-
Iroxanadine
Iroxanadine (BRX-005) is a Novel small molecule MAPK p38 inhibitor that induces phosphorylation of p38 SAPK and induces concentration-dependent relaxation in guinea pig pulmonary artery preparations precontracted with phenylephrine.
